Katia Khoury

Katia Khoury practices at University of Alabama at Birmingham in Birmingham, Alabama.

Katia Khoury's NPI, 1013322445, was assigned on June 24, 2014. Katia Khoury holds Alabama license 40413.

Katia Khoury's primary practice is University of Alabama at Birmingham, at 618 19th N St, Birmingham, AL 35203 in Jefferson County. The practice phone is (205) 934-6600.

Katia Khoury's primary practice is University of Alabama at Birmingham in Birmingham, Alabama. Katia Khoury is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Katia Khoury to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Katia Khoury practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Katia Khoury's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Katia Khoury is licensed in Alabama.

CMS data shows 375 Medicare services from Katia Khoury across 4 procedure codes in 2024, for 145 Medicare patients. Medicare paid $20,104 for them.

CMS counts 145 Medicare patients who saw Katia Khoury in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have cancer, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Katia Khoury's median patient age at 61, with 98% women.

In 2024, Katia Khoury wrote 1,172 Medicare Part D claims for 266 patients. 86% of them were for generic drugs. CMS names the drug for 988 of them, across 15 drugs with 11 or more claims each, at $2,012,304 in total drug cost. In 2023, CMS named 834 claims across 16 drugs.

Katia Khoury accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Katia Khoury as offering telehealth.

Dmand AI links 19 papers to Katia Khoury, published from 2013 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Trastuzumab and Receptor, ErbB-2. Katia Khoury has published most often in Breast Cancer Res Treat. Katia Khoury's most frequent co-authors are Erica Stringer-Reasor, Paula Raffin Pohlmann, MD and Hussein Assi, MD.

CMS Open Payments shows 36 general payments to Katia Khoury from 10 drug and device companies from 2017 to 2025. Device or supply loans make up the largest share, 54% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,890.